Figure 1.
Patient Disposition in the OLE. For those patients who discontinued from study participation for more than one reason, only the primary reason is listed. Abbreviations: ADA, adalimumab; OLE, open‐label extension; pbo, placebo.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.